Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
Von Ayzenberg et al, erschienen in „J Neurol.“ (Vol. 263, Nr. 3, März 2016)
-
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity
Von Luchtman et al, erschienen in „J Neurochem“ (Vol. 136, Nr. 5, März 2016)
-
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research
Von Hohlfeld et al, erschienen in „Lancet Neurol.“ (Vol. 15, Nr. 3, März 2016)
-
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease
Von Flach et al, erschienen in „Proc Natl Acad Sci U S A.“ (Vol. 113, Nr. 12, März 2016)
-
Fine-tuning of type I IFN-signaling in microglia- implications for homeostasis, CNS autoimmunity and interferonopathies
Von Goldmann et al, erschienen in „Curr Opin Neurobiol“ (Vol. 36, Februar 2016)
-
CNS myeloid cells as drug targets: current status and translational challenges
Von Biber et al, erschienen in „Nat Rev Drug Disc“ (Vol. 15, Nr. 2, Februar 2016)
-
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Von Kleiter et al, erschienen in „Ann Neurol.“ (Vol. 79, Nr. 2, Februar 2016)
-
Structural correlates for fatigue in early relapsing remitting multiple sclerosis
Von Wilting et al, erschienen in „European Radiology“ (Vol. 26, Nr. 2, Februar 2016)
-
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Von Metz et al, erschienen in „Neurol Neuroimmunol Neuroinflamm.“ (Vol. 3, Nr. 2, Februar 2016)
-
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
Von Schwab et al, erschienen in „Neurol Neuroimmunol Neuroinflamm“ (Vol. 3, Februar 2016)